The View From the C-Suite: Buying Girth in the Global Market

The transcript discusses a $62 billion acquisition of Shire, highlighting its significance in the healthcare industry. It explores the ongoing consolidation in the industry, driven by high R&D costs and the need for global reach. The challenges and risks of large acquisitions are examined, emphasizing the importance of strategic vision and risk management. The conversation also touches on innovation and drug pricing, particularly in the context of rare diseases. Strategies for successful integration post-acquisition are discussed, with a focus on speed and leadership. The decision to keep the global headquarters in Japan is also addressed.

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF